DoW Pancreatic Cancer Research Program, Idea Development Award

The DoW Pancreatic Cancer Research Program, Idea Development Award, supports the development of innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements in improving outcomes for individuals with pancreatic cancer. This award mechanism supports innovative ideas with the potential to yield impactful data and new avenues of investigation. All applications must address at least one of the FY26 PCARP Focus Areas. The award requires preliminary data relevant to the proposed project and can support clinical research studies, but does not allow clinical trials. • The award mechanism offers a higher level of funding for applications that propose to partner an experienced PI with an Early-Career Investigator wishing to pursue a career in pancreatic cancer research. • The estimated funding for this opportunity is $9,900,000, and the number of awards is 12. • The opportunity is open to any type of entity, subject to any clarification in the text field entitled "Additional Information on Eligibility". • The award does not require cost sharing.